These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 127607)

  • 1. Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum.
    Mui PT; James HL; Ganguly P
    Br J Haematol; 1975 Apr; 29(4):627-37. PubMed ID: 127607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):360-9. PubMed ID: 47244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measurement of human plasma antiplasmin activity by radial diffusion assay.
    Andes WA
    Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma.
    Collen D; Wiman B
    Blood; 1979 Feb; 53(2):313-24. PubMed ID: 153773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.
    Joist JH; Niewiarowski S; Nath N; Mustard JF
    J Lab Clin Med; 1976 Apr; 87(4):659-69. PubMed ID: 131845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
    Edy J; Collen D
    Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of plasmin by normal and antiplasmin-depleted human plasma.
    Edy J; De Cock F; Collen D
    Thromb Res; 1976 Apr; 8(4):513-8. PubMed ID: 131986
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in antiplasmin and plasmin activities during extreme hemodilution and open heart surgery in dogs.
    Aasen AO; Gallimore MJ; Lilleaasen P; Lyngaas K; Larsbraaten M; Amundsen E
    Eur Surg Res; 1979; 11(3):145-53. PubMed ID: 159822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin inhibitory effect of rat tissues: comparison with antiplasmin activity of plasma.
    Padró T; van den Hoogen CM; Emeis JJ
    Scand J Clin Lab Invest; 1991 Nov; 51(7):599-603. PubMed ID: 1839750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence and release of alpha 2-antiplasmin from human platelets.
    Plow EF; Collen D
    Blood; 1981 Dec; 58(6):1069-74. PubMed ID: 7306699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low molecular weight antiplasmin of human blood platelets.
    Ganguly P
    Clin Chim Acta; 1972 Jul; 39(2):466-8. PubMed ID: 4625471
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):370-84. PubMed ID: 1122293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin-antiplasmin complex formation during defibrase infusion in man.
    Collen D; Verstraete M
    Thromb Res; 1977 Sep; 11(3):417-20. PubMed ID: 144333
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrin powder turbidity measurement for rapid assessment of antiplasmins.
    Exner T; Rickard KA; Kronenberg H
    Am J Clin Pathol; 1975 Nov; 64(5):597-601. PubMed ID: 127526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin.
    Wiman B; Boman L; Collen D
    Eur J Biochem; 1978 Jun; 87(1):143-6. PubMed ID: 149657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.